Variant report
Variant | esv3450708 |
---|---|
Chromosome Location | chr1:153221928-153224626 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555908646 | chr1:153222034-153222035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575958983 | chr1:153222079-153222080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544514332 | chr1:153222096-153222097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564390419 | chr1:153222097-153222098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577862549 | chr1:153222100-153222101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540417316 | chr1:153222101-153222102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189807384 | chr1:153222165-153222166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs151175542 | chr1:153222225-153222226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182120376 | chr1:153222238-153222239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532967197 | chr1:153222286-153222287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148213046 | chr1:153222311-153222312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115461136 | chr1:153222355-153222356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140123438 | chr1:153222360-153222361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75828937 | chr1:153222400-153222401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372101263 | chr1:153222510-153222511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145230098 | chr1:153222530-153222531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185319549 | chr1:153222587-153222588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138502002 | chr1:153222609-153222610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547256385 | chr1:153222616-153222617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7532289 | chr1:153222657-153222658 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs190902139 | chr1:153222683-153222684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111238351 | chr1:153222841-153222842 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184043310 | chr1:153222852-153222853 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370691625 | chr1:153222870-153222871 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7554266 | chr1:153222881-153222882 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs543628896 | chr1:153222939-153222940 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558068910 | chr1:153222987-153222988 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577901889 | chr1:153223042-153223043 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540452674 | chr1:153223089-153223090 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113846127 | chr1:153223099-153223100 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574141240 | chr1:153223130-153223131 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367909454 | chr1:153223131-153223132 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542762960 | chr1:153223132-153223133 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377094365 | chr1:153223150-153223151 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562999122 | chr1:153223173-153223174 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531780987 | chr1:153223205-153223206 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201605423 | chr1:153223211-153223212 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192996335 | chr1:153223227-153223228 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565365423 | chr1:153223228-153223229 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572696236 | chr1:153223239-153223240 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529355235 | chr1:153223245-153223246 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146141104 | chr1:153223264-153223265 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527606023 | chr1:153223276-153223277 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138970581 | chr1:153223295-153223296 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567360064 | chr1:153223309-153223310 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536400738 | chr1:153223312-153223313 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549655687 | chr1:153223323-153223324 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569401150 | chr1:153223383-153223384 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538281607 | chr1:153223386-153223387 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374912367 | chr1:153223394-153223395 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153217600-153222200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:153221000-153224200 | Enhancers | Fetal Brain Male | brain |
3 | chr1:153221200-153223400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr1:153222200-153222600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr1:153222200-153223000 | Enhancers | Brain Angular Gyrus | brain |
6 | chr1:153222800-153223000 | Enhancers | Esophagus | oesophagus |
7 | chr1:153222800-153223400 | Bivalent Enhancer | Adipose Nuclei | Adipose |
8 | chr1:153223000-153223400 | Bivalent/Poised TSS | Fetal Kidney | kidney |
9 | chr1:153223000-153224000 | Weak transcription | Esophagus | oesophagus |
10 | chr1:153223400-153223800 | Enhancers | Adipose Nuclei | Adipose |
11 | chr1:153223400-153225800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr1:153223600-153225000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
13 | chr1:153224000-153224400 | Enhancers | Esophagus | oesophagus |
14 | chr1:153224000-153224800 | Enhancers | GM12878-XiMat | blood |
15 | chr1:153224200-153227800 | Weak transcription | Fetal Brain Male | brain |
16 | chr1:153224400-153224600 | Weak transcription | Esophagus | oesophagus |
17 | chr1:153224600-153225000 | Enhancers | Esophagus | oesophagus |